This case report elucidates the impact of mpox ocular infections on patients with advanced HIV infection.
Opioid Misuse Among People With HIV: Results From the National Survey on Drug Use and Health (NSDUH) 2015-2019
Source : https://pubmed.ncbi.nlm.nih.gov/38293795/
Aim: Pain is a major challenge in the management of HIV/AIDS. This research analyzed the prevalence of substance use and opioid misuse among people with HIV (PWH) and those without...
People living with HIV infection were about 1.88-times more likely to misuse pain relievers and 1.85-times to misuse opioids than people not infected with HIV, with a notable rise in hydrocodone and tramadol misuse.
Mpox disease progression occurred in 3 people living with HIV infection (PWH; 5.4%) in the early tecovirimat group and in 15 PWH (26.8%) in the late or no tecovirimat group.
Racial Inequities in HIV Incidence Among Men Who Have Sex With Men Prior to and Amidst an Ending the HIV Epidemic Initiative
Source : https://pubmed.ncbi.nlm.nih.gov/38265417/
Despite decreases in HIV incidence among MSM, racial inequities were exacerbated over time. Addressing structural factors that impact racial inequities in risk of HIV should undergird EHE initiatives.
Black and Latino men who have sex with men (MSM) seroconverted at significantly higher rates than White MSM in the same age groups and neighborhood poverty level.
Development and Validation of an Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry Method to Quantify Antiretroviral Drug Concentrations in Human Plasma for Therapeutic Monitoring
Source : https://pubmed.ncbi.nlm.nih.gov/38198884/
Antiretroviral therapy (ART) is highly effective for the treatment of HIV-1 infection. ART previously consisted of concomitant administration of many drugs, multiple times per day. Currently, ART generally consists of...
A team of researchers developed and validated a highly selective, ultra-performance liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of abacavir, bictegravir, cabotegravir, dolutegravir, doravirine, emtricitabine, lamivudine, raltegravir, and tenofovir in human plasma.